Frequently asked questions
Peptide prescribing in Australia — frequently asked questions
Answers to the most common questions about legality, doctor consults, costs, the TGA SAS-B pathway, and safety — reviewed by AHPRA-registered Australian prescribers.
Legality in Australia
- Is BPC-157 legal in Australia?
- BPC-157 is a Schedule 4 prescription-only substance in Australia. It is not registered on the ARTG, so it cannot be sold over the counter. It can be lawfully accessed via the TGA Special Access Scheme Category B (SAS-B), prescribed by an AHPRA-registered doctor and compounded by a TGA-licensed Australian pharmacy. Importing it personally without a script is unlawful under the Customs Act.
- Is CJC-1295 legal in Australia?
- Yes — CJC-1295 (with or without DAC) is legal when prescribed by an AHPRA-registered doctor under the TGA SAS-B pathway and dispensed by a TGA-licensed compounding pharmacy. It is Schedule 4 prescription-only. Self-importing from offshore vendors is unlawful.
- Is GHK-Cu legal in Australia?
- GHK-Cu is legal for cosmetic topical use at low concentrations and is widely sold in serums. Injectable GHK-Cu is Schedule 4 prescription-only and only lawful via an Australian SAS-B script compounded by a licensed Australian pharmacy.
- Is MOTS-c legal in Australia?
- MOTS-c is prescription-only and not ARTG-registered. AHPRA-registered Australian doctors can prescribe it under SAS-B on a case-by-case basis where clinically justified. Personal importation is unlawful.
- Is tirzepatide legal in Australia?
- Yes — tirzepatide (Mounjaro) is TGA-approved in Australia for type 2 diabetes and weight management in eligible adults. It is Schedule 4 and requires a prescription from an AHPRA-registered doctor.
- What is the TGA SAS-B pathway?
- The TGA Special Access Scheme Category B (SAS-B) lets Australian doctors prescribe medicines that are not on the ARTG when they have clinical grounds. The doctor lodges a notification with the TGA and the medicine is dispensed by a TGA-licensed pharmacy. Most compounded peptides in Australia are supplied this way.
Finding a doctor
- How do I find a doctor who prescribes peptides in Australia?
- Start the free 5-minute pre-qualification at peptidedoctorau.com/assessment. If you're clinically suitable you're matched with an AHPRA-registered Australian doctor for a $99 telehealth consult. The doctor reviews your history, confirms eligibility, and — where appropriate — issues a TGA SAS-B prescription to a licensed Australian compounding pharmacy.
- Can I get a peptide script via telehealth in Australia?
- Yes. AHPRA-registered Australian doctors can prescribe peptides via telehealth under TGA SAS-B after a clinical consultation. There is no requirement for an in-person visit for most peptide therapies, though pathology may be requested.
- How much does a peptide doctor consult cost in Australia?
- PeptideDoctorAU initial telehealth consults are $99 AUD. Follow-up review consults are typically $59–$79. Bulk billing is not available because compounded peptide prescribing is not covered by Medicare.
- How long until I get my prescription?
- Most patients have a SAS-B prescription issued within 24–48 hours of the consult. The compounding pharmacy then ships cold-chain in 2–4 business days (Mon–Wed dispatch).
- Do I need a referral from my GP?
- No referral is required. You can book a telehealth consult with an AHPRA-registered Australian doctor directly. Your GP can be copied on the consult summary if you wish.
Cost & pharmacy
- How much does BPC-157 cost in Australia?
- Compounded BPC-157 from an Australian SAS-B pharmacy typically costs AUD $180–$320 per month depending on dose and pharmacy. Plus the $99 initial consult.
- How much does CJC-1295 + Ipamorelin cost in Australia?
- A 1:1 blend of CJC-1295 (no-DAC) and Ipamorelin from an Australian compounding pharmacy is typically AUD $220–$380 per month, depending on dose.
- How much does tirzepatide cost in Australia?
- Tirzepatide (Mounjaro) in Australia is typically AUD $350–$600+ per month at private (non-PBS) pricing depending on dose. PBS subsidy applies only for type 2 diabetes patients meeting strict criteria.
- Are peptides covered by Medicare or private health?
- Compounded peptides under SAS-B are not covered by Medicare and are not covered by most private health funds. Tirzepatide is PBS-subsidised only for type 2 diabetes patients meeting criteria.
- What is a TGA-licensed compounding pharmacy?
- A pharmacy licensed by the TGA to manufacture sterile injectable medications. They follow PIC/S Good Manufacturing Practice and are audited regularly. All PeptideDoctorAU scripts route to TGA-licensed Australian compounding pharmacies only — never offshore.
Safety & side effects
- Are peptides safe?
- Peptides prescribed under SAS-B by an AHPRA-registered Australian doctor and compounded by a TGA-licensed pharmacy have a generally favourable safety profile for the indications they're reviewed for. Risks vary by peptide. Common, minor side effects include injection-site reactions, transient flushing, or vivid dreams. Doctors screen for contraindications including active cancer, pregnancy, breastfeeding, and several others.
- Who should NOT use peptides?
- Anyone pregnant or breastfeeding, under 18, with active or recent malignancy, severe uncontrolled cardiovascular disease, or specific peptide-relevant contraindications. Each peptide has its own screening criteria reviewed at consultation.
- Why should I not order peptides from overseas?
- Importing peptides yourself from offshore 'research chemical' vendors is unlawful under the Customs Act, gives no sterility or potency guarantee, and leaves you with no Australian doctor if something goes wrong. The lawful path is AHPRA doctor → TGA SAS-B → TGA-licensed Australian compounding pharmacy.
- Are peptides banned in sport?
- Many peptides — including BPC-157, TB-500, CJC-1295, Ipamorelin, and GH secretagogues — are on the WADA Prohibited List for athletes in competition. Athletes subject to WADA testing should not use these without a Therapeutic Use Exemption.
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026.
Question not answered?
Start the free 5-minute pre-qualification. An AHPRA-registered Australian doctor will review your case and answer your specific clinical questions at the $99 telehealth consult.
Start free assessment